CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.36B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.18: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.17BCNY1.36B · vs all stocks (USD)
Trailing P/E
79.19xRevenue (TTM)
10.20BCNY1.51B · vs all stocks (USD)
Profit Margin
1.09%Beta
0.2020xvs all stocks
52-Week Change
-28.84%vs all stocks
Market Capitalization
9.17BCNY1.36B · vs all stocks (USD)
Enterprise Value
13.44BCNY2.00B · vs all stocks (USD)
Trailing P/E
79.19xForward P/E
9.04xPrice to Sales (TTM)
0.8990xPrice to Book (MRQ)
2.57xEnterprise to Revenue
1.32xEnterprise to EBITDA
21.42xGross Margin
35.79%Profit Margin
1.09%Operating Margin
3.78%Return on Assets (TTM)
1.00%Return on Equity (TTM)
3.01%Revenue (TTM)
10.20BCNY1.51B · vs all stocks (USD)
Revenue per Share (TTM)
18.84CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-10.60%Gross Profit (TTM)
3.13BCNY465.35M · vs all stocks (USD)
EBITDA (TTM)
483.18MCNY71.76M · vs all stocks (USD)
Net Income (TTM)
111.65MCNY16.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-12.00%Operating Cash Flow (TTM)
346.97MCNY51.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-104.29MCNY-15.49M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
140.23MCNYFY2025 · Dec 31, 2025Revenue
10.50BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.39BCNYFY2025 · Dec 31, 2025Gross Profit
3.11BCNYFY2025 · Dec 31, 2025Operating Income
435.10MCNY64.62M · vs all stocks (USD)
Pre-tax Income
221.11MCNYFY2025 · Dec 31, 2025Income Tax Expense
100.48MCNYFY2025 · Dec 31, 2025Net Income
120.63MCNYFY2025 · Dec 31, 2025EBIT
359.34MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
867.99MCNYFY2025 · Dec 31, 2025Research & Development
257.54MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.15BCNYFY2025 · Dec 31, 2025Other Operating Expenses
125.20MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
138.23MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
548.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
548.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
120.63MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-56.49KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-51.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
-509.46MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
933.04MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
120.63MCNYFY2025 · Dec 31, 2025Other Non-cash Items
158.21MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-868.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
537.61MCNYFY2025 · Dec 31, 2025Capital Expenditures
-457.62MCNYFY2025 · Dec 31, 2025Sale of Investments
73.97MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-383.65MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
5.10BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-4.72BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-120.99MCNYFY2025 · Dec 31, 2025Other Financing Charges
-207.75MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
54.54MCNYFY2025 · Dec 31, 2025Shares Outstanding
551.42MSharesUpdated Aug 20, 2026Float Shares
335.75MSharesUpdated Aug 20, 2026% Held by Insiders
40.08%vs all stocks
% Held by Institutions
4.00%vs all stocks
Total Cash (MRQ)
732.10MCNY108.73M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.33CNYUpdated Aug 20, 2026Total Debt (MRQ)
5.54BCNY823.30M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.49xCurrent Ratio (MRQ)
0.7380xBook Value per Share (MRQ)
6.47CNYUpdated Aug 20, 2026Total Assets
14.41BCNY2.14B · vs all stocks (USD)
Total Current Assets
7.03BCNYFY2025 · Dec 31, 2025Total Liabilities
10.77BCNYFY2025 · Dec 31, 2025Total Non-current Assets
7.38BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.06BCNYFY2025 · Dec 31, 2025Total Current Liabilities
9.71BCNYFY2025 · Dec 31, 2025Cash
592.94MCNYFY2025 · Dec 31, 2025Cash Equivalents
508.54MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.10BCNYFY2025 · Dec 31, 2025Other Short-term Investments
68.46MCNYFY2025 · Dec 31, 2025Accounts Receivable
2.14BCNYFY2025 · Dec 31, 2025Inventory
2.20BCNYFY2025 · Dec 31, 2025Accounts Payable
2.44BCNYFY2025 · Dec 31, 2025Short-term Debt
4.97BCNYFY2025 · Dec 31, 2025Other Current Liabilities
341.95MCNYFY2025 · Dec 31, 2025Long-term Debt
464.67MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
551.42MCNYFY2025 · Dec 31, 2025Retained Earnings
823.83MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.64BCNY540.87M · vs all stocks (USD)
52-Week Low
11.56CNYUpdated Aug 20, 202652-Week High
23.98CNYUpdated Aug 20, 202652-Week Change
-28.84%vs all stocks
Beta
0.2020xvs all stocks
50-Day MA
14.94CNYUpdated Aug 20, 2026200-Day MA
16.62CNYUpdated Aug 20, 2026Avg 10-Day Volume
42.26MSharesUpdated Aug 20, 2026Avg 30-Day Volume
40.74MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2100CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.18: grey zoneSignificant
Altman Z-Score: 1.18
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.36B, above the global median of $1.15BNotable
Market cap (USD): 1,361,940,937.464Global Median: 1,146,734,693.424
Revenue is $1.51B, above the global median of $520.53MNotable
Revenue (USD): 1,514,966,734.848Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
GenFleet Therapeutics (Shanghai) Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Phibro Animal Health Corporation
Tier 1ProductionApproval-Gated PipelineRule
EL.En. S.p.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Novavax Inc.
Tier 1ProductionApproval-Gated PipelineRule
Changzhou Qianhong Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Qingdao Haier Biomedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Aurisco Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Ch. Karnchang Public Company Limited
1 interpretationWithin or Near the Altman Distress Zone
Shandong Longda Meishi Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone
China High-Speed Railway Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone